Strategic investors are taking a renewed interest in the Fidelity® Quality Factor ETF (FQAL) as of late March 2026. A significant valuation reset has positioned the quality factor notably below its long-term average, potentially setting the stage for a multi-year trend reversal. The fund continues to adhere to its established sector-neutral investment approach.

Attractive Valuation Following a Correction

The current fundamental picture presents a key consideration for market participants. Although quality-focused strategies entered 2025 trading at elevated valuations, a correction through early March 2026 has created a new entry point. The quality factor now trades approximately one standard deviation below its long-term relative valuation. Historically, such adjustments in factor investing have frequently preceded extended periods of outperformance.

This potential opportunity is paired with the fund's cost-efficient structure. With a total expense ratio of 0.15%, FQAL positions itself as a competitively priced option compared to the category average. Managing assets of approximately $1.15 billion, the ETF provides a substantial and established vehicle for factor exposure.

Sector-Neutral Strategy Mitigates Concentration Risk

Should investors sell immediately? Or is it worth buying Fidelity® Quality Factor ETF?

FQAL employs a specific methodology: it targets U.S. companies demonstrating high earnings stability and robust balance sheets while strictly maintaining sector neutrality. This disciplined approach helps the management team avoid concentrated risks in industries that naturally exhibit high-quality characteristics, such as technology or consumer staples.

Despite this neutrality mandate, information technology constitutes the largest portfolio allocation at about 32.80%, followed by financial services at 12.54%. The fund's basket of roughly 130 holdings includes major market leaders like NVIDIA, Apple, Alphabet, Microsoft, and Broadcom. This emphasis on established, profitable companies reinforces the strategy's core objective.

Investors may also note the fund's cyclical rebalancing schedule. The next scheduled index reconstitution is set for August, following the completion of the last rebalancing phase in February. The combination of low fees and the current discount to historical valuation norms makes this ETF a compelling tool for investors anticipating a broad recovery in quality stocks.

Ad

Fresh Fidelity® Quality Factor ETF information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.